30 results on '"Zambakides A"'
Search Results
2. Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions
- Author
-
Rafeh, Nidal Abi, Agostoni, Pierfrancesco, Alaswad, Khaldoon, Araya, Mario, Avran, Alexandre, Ayoub, Mohamed, Azzalini, Lorenzo, Babunashvili, Avtandil M., Bayani, Baktash, Behnes, Michael, Bhindi, Ravinay, Boudou, Nicolas, Boukhris, Marouane, Bozinovic, Nenad Z., Bryniarski, Leszek, Bufe, Alexander, Buller, Christopher E., Burke, M. Nicholas, Buettner, Heinz Joachim, Cardoso, Pedro, Carlino, Mauro, Chan, Chi-Kin, Chen, Jiyan, Christiansen, Evald Hoej, Colombo, Antonio, Croce, Kevin, Damas de los Santos, Felix, de Martini, Tony, Dens, Joseph, di Mario, Carlo, Doshi, Darshan, Dou, Kefei, Egred, Mohaned, Elbarouni, Basem, ElGuindy, Ahmed M., Escaned, Javier, Furkalo, Sergey, Gagnor, Andrea, Galassi, Alfredo R., Garbo, Roberto, L.Gasparini, Gabriele, Ge, Junbo, Ge, Lei, Goel, Pravin Kumar, Goktekin, Omer, Gonzalo, Nieves, Gorgulu, Sevket, Grancini, Luca, Hall, Allison B., Hanratty, Colm, Harb, Stefan, Harding, Scott A., Hatem, Raja, Hellig, Farrel, Henriques, Jose P.S., Hildick-Smith, David, Hill, Jonathan M., Hoye, Angela, Jaber, Wissam, Jaffer, Farouc A., Jang, Yangsoo, Jussila, Risto, Kalnins, Artis, Kalra, Sanjog, Kandzari, David E., Kao, Hsien-Li, Karmpaliotis, Dimitri, Kassem, Hussien Heshmat, Kearney, Kathleen E., Kerrigan, Jimmy, Khatri, Jaikirshan, Khelimskii, Dmitri, Kirtane, Ajay J., Knaapen, Paul, Kornowski, Ran, Krestyaninov, Oleg, Kumar, V. Ganesh, Kumar, Prathap, Lamelas, Pablo Manuel, Lee, Seung-Whan, Lefevre, Thierry, Leibundgut, Gregor, Leung, Raymond, Leung, Sum-Kin, Li, Yu, Li, Yue, Lim, Soo-Teik, Lo, Sidney, Lombardi, William, Maran, Anbukarasi, McEntegart, Margaret, Moses, Jeffrey, Munawar, Muhammad, Nagamatsu, Wataru, Navarro, Andres, Ngo, Hung M., Nicholson, William, Oksnes, Anja, Olivecrona, Goran K., Padilla, Lucio, Patel, Mitul, Pershad, Ashish, Postu, Marin, Pyxaras, Stylianos, Qian, Jie, Quadros, Alexandre, Hanna Quesada, Franklin Leonardo, Råmunddal, Truls, Rao, Vithala Suryaprakasa, Rathore, Sudhir, Reifart, Nicolaus, Riley, Robert F., Rinfret, Stephane, Saghatelyan, Meruzhan, Santiago, Ricardo, Seth, Ashok, Sianos, Georgios, Smith, Elliot, Spaedy, Anthony, Spratt, James, Stone, Gregg W., Strange, Julian W., Tammam, Khalid O., Thompson, Craig A., Toma, Aurel, Tremmel, Jennifer A., Ungi, Imre, Vadalà, Giuseppe, Vo, Minh, Vu, Vu Hoang, Walsh, Simon, Weilenmann, Daniel, Werner, Gerald S., Wojcik, Jaroslaw, Wollmuth, Jason, Wu, Chiung-Jen, Xu, Bo, Yamane, Masahisa, Ybarra, Luiz F., Yeh, Robert W., Zambakides, Chris, Zhang, Qi, Wu, Eugene B., Kalyanasundaram, Arun, Brilakis, Emmanouil S., Mashayekhi, Kambis, and Tsuchikane, Etsuo
- Published
- 2024
- Full Text
- View/download PDF
3. Prognostic factors in high-grade pediatric osteosarcoma among children and young adults: Greek Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) data along with a systematic review and meta-analysis
- Author
-
Papakonstantinou, Evgenia, Athanasiadou, Kleoniki I., Markozannes, Georgios, Tzotzola, Vassiliki, Bouka, Evdoxia, Baka, Margarita, Moschovi, Maria, Polychronopoulou, Sophia, Hatzipantelis, Emmanuel, Galani, Vasiliki, Stefanaki, Kalliopi, Strantzia, Katerina, Vousvouki, Maria, Kourou, Panagiota, Magkou, Evgenia, Nikita, Maria, Zambakides, Christos, Michelarakis, John, Alexopoulou, Aikaterini, Gavra, Maro, Malama, Astero, Ntzani, Evangelia E., and Petridou, Eleni Th.
- Published
- 2024
- Full Text
- View/download PDF
4. Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions
- Author
-
Wu, Eugene B., primary, Kalyanasundaram, Arun, additional, Brilakis, Emmanouil S., additional, Mashayekhi, Kambis, additional, Tsuchikane, Etsuo, additional, Rafeh, Nidal Abi, additional, Agostoni, Pierfrancesco, additional, Alaswad, Khaldoon, additional, Araya, Mario, additional, Avran, Alexandre, additional, Ayoub, Mohamed, additional, Azzalini, Lorenzo, additional, Babunashvili, Avtandil M., additional, Bayani, Baktash, additional, Behnes, Michael, additional, Bhindi, Ravinay, additional, Boudou, Nicolas, additional, Boukhris, Marouane, additional, Bozinovic, Nenad Z., additional, Bryniarski, Leszek, additional, Bufe, Alexander, additional, Buller, Christopher E., additional, Burke, M. Nicholas, additional, Buettner, Heinz Joachim, additional, Cardoso, Pedro, additional, Carlino, Mauro, additional, Chan, Chi-Kin, additional, Chen, Jiyan, additional, Christiansen, Evald Hoej, additional, Colombo, Antonio, additional, Croce, Kevin, additional, Damas de los Santos, Felix, additional, de Martini, Tony, additional, Dens, Joseph, additional, di Mario, Carlo, additional, Doshi, Darshan, additional, Dou, Kefei, additional, Egred, Mohaned, additional, Elbarouni, Basem, additional, ElGuindy, Ahmed M., additional, Escaned, Javier, additional, Furkalo, Sergey, additional, Gagnor, Andrea, additional, Galassi, Alfredo R., additional, Garbo, Roberto, additional, L.Gasparini, Gabriele, additional, Ge, Junbo, additional, Ge, Lei, additional, Goel, Pravin Kumar, additional, Goktekin, Omer, additional, Gonzalo, Nieves, additional, Gorgulu, Sevket, additional, Grancini, Luca, additional, Hall, Allison B., additional, Hanratty, Colm, additional, Harb, Stefan, additional, Harding, Scott A., additional, Hatem, Raja, additional, Hellig, Farrel, additional, Henriques, Jose P.S., additional, Hildick-Smith, David, additional, Hill, Jonathan M., additional, Hoye, Angela, additional, Jaber, Wissam, additional, Jaffer, Farouc A., additional, Jang, Yangsoo, additional, Jussila, Risto, additional, Kalnins, Artis, additional, Kalra, Sanjog, additional, Kandzari, David E., additional, Kao, Hsien-Li, additional, Karmpaliotis, Dimitri, additional, Kassem, Hussien Heshmat, additional, Kearney, Kathleen E., additional, Kerrigan, Jimmy, additional, Khatri, Jaikirshan, additional, Khelimskii, Dmitri, additional, Kirtane, Ajay J., additional, Knaapen, Paul, additional, Kornowski, Ran, additional, Krestyaninov, Oleg, additional, Kumar, V. Ganesh, additional, Kumar, Prathap, additional, Lamelas, Pablo Manuel, additional, Lee, Seung-Whan, additional, Lefevre, Thierry, additional, Leibundgut, Gregor, additional, Leung, Raymond, additional, Leung, Sum-Kin, additional, Li, Yu, additional, Li, Yue, additional, Lim, Soo-Teik, additional, Lo, Sidney, additional, Lombardi, William, additional, Maran, Anbukarasi, additional, McEntegart, Margaret, additional, Moses, Jeffrey, additional, Munawar, Muhammad, additional, Nagamatsu, Wataru, additional, Navarro, Andres, additional, Ngo, Hung M., additional, Nicholson, William, additional, Oksnes, Anja, additional, Olivecrona, Goran K., additional, Padilla, Lucio, additional, Patel, Mitul, additional, Pershad, Ashish, additional, Postu, Marin, additional, Pyxaras, Stylianos, additional, Qian, Jie, additional, Quadros, Alexandre, additional, Hanna Quesada, Franklin Leonardo, additional, Råmunddal, Truls, additional, Rao, Vithala Suryaprakasa, additional, Rathore, Sudhir, additional, Reifart, Nicolaus, additional, Riley, Robert F., additional, Rinfret, Stephane, additional, Saghatelyan, Meruzhan, additional, Santiago, Ricardo, additional, Seth, Ashok, additional, Sianos, Georgios, additional, Smith, Elliot, additional, Spaedy, Anthony, additional, Spratt, James, additional, Stone, Gregg W., additional, Strange, Julian W., additional, Tammam, Khalid O., additional, Thompson, Craig A., additional, Toma, Aurel, additional, Tremmel, Jennifer A., additional, Ungi, Imre, additional, Vadalà, Giuseppe, additional, Vo, Minh, additional, Vu, Vu Hoang, additional, Walsh, Simon, additional, Weilenmann, Daniel, additional, Werner, Gerald S., additional, Wojcik, Jaroslaw, additional, Wollmuth, Jason, additional, Wu, Chiung-Jen, additional, Xu, Bo, additional, Yamane, Masahisa, additional, Ybarra, Luiz F., additional, Yeh, Robert W., additional, Zambakides, Chris, additional, and Zhang, Qi, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Acute Coronary Syndromes in Treatment-Naïve Black South Africans with Human Immunodeficiency Virus Infection
- Author
-
BECKER, A. C., SLIWA, K., STEWART, S., LIBHABER, E., ESSOP, A. R., ZAMBAKIDES, C. A., and ESSOP, M.R.
- Published
- 2010
- Full Text
- View/download PDF
6. Spondyloepiphyseal dysplasia: A rare cause of short stature
- Author
-
Ioannis Panagiotopoulos, Christos Zambakides, Elli Anagnostou, Vassilios Papadakis, Elpis Vlachopapadopoulou, Stefanos Michalacos, and Eirini Dikaiakou
- Subjects
Spondyloepiphyseal dysplasia ,Pediatrics ,medicine.medical_specialty ,business.industry ,medicine ,General Medicine ,medicine.symptom ,business ,Short stature - Published
- 2017
7. Spondyloepiphyseal dysplasia: A rare cause of short stature
- Author
-
Vlachopapadopoulou, Elpis, primary, Dikaiakou, Eirini, additional, Panagiotopoulos, Ioannis, additional, Zambakides, Christos, additional, Anagnostou, Elli, additional, Papadakis, Vassilios, additional, and Michalacos, Stefanos, additional
- Published
- 2017
- Full Text
- View/download PDF
8. Therapy of Ischemic Cardiomyopathy With the Immunomodulating Agent Pentoxifylline
- Author
-
Danelle Badenhorst, Rafique Essop, Chris Zambakides, Karen Sliwa, Veuvette N. Kone, Angela J. Woodiwiss, Geoffrey P. Candy, Ferande Peters, and Gavin R. Norton
- Subjects
Male ,medicine.medical_specialty ,Heart Ventricles ,Myocardial Ischemia ,Cardiomyopathy ,Blood Pressure ,Nerve Tissue Proteins ,Radionuclide ventriculography ,Ventricular Function, Left ,Pentoxifylline ,Adjuvants, Immunologic ,Double-Blind Method ,Physiology (medical) ,Internal medicine ,Natriuretic Peptide, Brain ,medicine ,Humans ,fas Receptor ,Ultrasonography ,Ischemic cardiomyopathy ,Ejection fraction ,biology ,Tumor Necrosis Factor-alpha ,business.industry ,C-reactive protein ,Middle Aged ,medicine.disease ,Brain natriuretic peptide ,Peptide Fragments ,Surgery ,C-Reactive Protein ,Heart failure ,Exercise Test ,Cardiology ,biology.protein ,Female ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
Background— Inflammatory immune activation commonly occurs in heart failure and may perpetuate this syndrome. We sought to determine whether the immunomodulating agent pentoxifylline enhances left ventricular function in patients with ischemic cardiomyopathy. We also investigated the effect of therapy on levels of brain natriuretic peptide (NT-pro BNP), C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), and the marker of apoptosis, Fas/Apo-1. Methods and Results— In a single-center, prospective, randomized, double-blind, placebo-controlled study, 38 patients with ischemic cardiomyopathy received pentoxifylline 400 mg TID or placebo in addition to standard therapy. Clinical assessment, radionuclide ventriculography, echocardiography, and blood analyses were performed at baseline and after 6 months. There were no differences in baseline characteristics between the groups. Five patients died (4 in the placebo group). Pentoxifylline treatment resulted in an improvement in functional class ( P P P Conclusions— In patients with heart failure due to ischemic left ventricular dysfunction, the addition of pentoxifylline to standard therapy results in improvements in clinical status and radionuclide ejection fraction, which are accompanied by reductions in plasma markers of inflammation, prognosis, and apoptosis.
- Published
- 2004
9. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
- Author
-
Tricoci, P, Huang, Z, Held, C, Moliterno, Dj, Armstrong, Pw, Van de Werf, F, White, Hd, Aylward, Pe, Wallentin, L, Chen, E, Lokhnygina, Y, Pei, J, Leonardi, S, Rorick, Tl, Kilian, Am, Jennings, Lh, Ambrosio, G, Bode, C, Cequier, A, Cornel, Jh, Diaz, R, Erkan, A, Huber, K, Hudson, Mp, Jiang, L, Jukema, Jw, Lewis, Bs, Lincoff, Am, Montalescot, G, Nicolau, Jc, Ogawa, H, Pfisterer, M, Prieto, Jc, Ruzyllo, W, Sinnaeve, Pr, Storey, Rf, Valgimigli, M, Whellan, Dj, Widimsky, P, Strony, J, Harrington, Ra, Mahaffey, Kw, Huo, Y, Lixin, J, Isaza, D, Grande, P, Laine, M, Wong, L, Ofner, P, Yamaguchi, T, Park, Sj, Nordrehaug, Je, Providencia, L, Cheem, Th, Dalby, A, Betriu, A, Chen, Mf, Verheugt, F, Frye, Rl, Hochman, J, Steg, Pg, Bailey, Kr, Easton, Jd, Lincoff, A, Underwood, Fd, Wrestler, J, Larson, D, Vandyne, B, Kilian, A, Harmelin-Kadouri, R, Layton, L, Lipka, L, Petrauskas, S, Qidwai, M, Sorochuck, C, Temple, T, Mason, D, Sydlowski, D, Gallagher, B, Villasin, A, Beernaert, A, Douglas, S, Garrett, J, Wiering, J, Adriaenssens, T, Ganame, J, Hulselmans, M, Katz, Jn, Kayaert, P, La Gerche, A, Onsea, K, Zalewski, J, Johnson, A, O'Briant, J, Smith, M, Akerblom, A, Armaganijan, L, Bertolami, A, Brennan, M, da Ponte Nacif SA, de Campos Gonzaga, C, Dequadros, A, Déry, Jp, Dev, S, Ducrocq, G, Eapen, Zp, Echenique, L, Eggers, K, Garcia, H, Guimaraes, Hp, Hagstrom, E, Hanet, C, James, S, Jonelid, B, Kolls, Bj, Leiria, T, Leite, R, Lombardi, C, Lopes, Rd, Malagutti, P, Mathews, R, Mehta, Rh, Melloni, C, Piccini, Jp, Rodriques Soares, P, Roe, Mt, Shah, Br, Stashenko, G, Szczech, La, Truffa, A, Varenhorst, C, Vranckx, P, Williams, J, Kilaru, R, White, Ja, Binkowitz, B, He, W, Ramos, Ms, Hasbani, E, Farras, Ha, Luz del Valle, L, Zapata, G, Centeno, Ep, Hominal, M, Beloscar, J, Panno, M, Berli, M, Carlevaro, O, Wasserman, T, Lembo, L, Diez, F, Bettinotti, M, Allall, O, Macin, S, Hii, C, Bett, N, Aroney, C, Roberts-Thomson, P, Arstall, M, Horowitz, J, Prasan, A, Farshid, A, Rankin, J, Duffy, S, Sinhal, A, Hendricks, R, Waites, J, Hill, A, French, J, Adams, M, Soward, A, Dick, R, Jepson, N, Nelson, G, Thompson, P, Neunteufl, T, Pachinger, O, Leisch, F, Siostrzonek, P, Roithinger, F, Pieske, B, Weber, H, Eber, B, Zenker, G, Sinnaeve, P, Roosen, J, Vervoort, G, Coussement, P, Striekwold, H, Boland, J, Van Dorpe, A, Dujardin, K, Mertens, D, Vanneste, L, Celen, H, Lesseliers, H, Vrolix, M, Leone, A, De Maeseneire, S, Hellemans, S, Silva, Fa, Franken, M, Moraes JB Jr, Mora, R, Michalaros, Y, Perin, M, Guimaraes, Ae, da Silva DG, Mattos, Ma, Alves AR Jr, Hernandes, Me, Golin, V, da Silva SA, Ardito, W, Dery, Jp, Mukherjee, A, Tanguay, Jf, Kornder, J, Lutchmedial, S, Degrace, M, Klinke, P, Constance, C, Nogareda, G, Wong, G, Macdonald, P, Senaratne, M, Rupka, D, Halperin, F, Ramanathan, K, Natarajan, M, Lai, C, Brossoit, R, Tymchak, W, Rose, B, Dupuis, R, Mansour, S, Bata, I, Zadra, R, Turek, M, Madan, M, Le May, M, Leon, L, Perez, L, Yovaniniz, P, Pedemonte, O, Campos, P, Pincetti, C, Sepulveda, P, Li, W, Zhao, R, Li, Z, Yang, Y, Chen, J, Li, H, Jiang, Y, Li, D, Qu, P, Sun, Y, Zheng, Y, Zhou, C, Zhang, F, Wei, M, Wang, D, Lemus, J, Fernandez, Rl, Jaramillo, C, Ochoa, J, Velez, S, Cano, N, Lutz, J, Botero, R, Jaramillo, M, Saaib, J, Sanchez, G, Hernandez, H, Mendoza, F, Rizcala, A, Urina, M, Polasek, R, Motovska, Z, Zemanek, D, Ostransky, J, Kettner, J, Spinar, J, Groch, L, Ramik, C, Stumar, J, Linhart, A, Pleva, L, Niedobova, E, Macha, J, Vojacek, J, Stipal, R, Galatius, S, Eggert, S, Mickley, H, Egstrup, K, Pedersen, O, Hvilsted, L, Sykulski, R, Skagen, K, Dodt, K, Klarlund, K, Husted, S, Jensen, G, Melchior, T, Sjoel, A, Steffensen, Fh, Airaksinen, Ke, Laukkanen, Ja, Syvanne, Ms, Kotila, Mj, Mikael, K, Naveri, Hk, Hekkala, Am, Mustonen, Jn, Halkosaari, M, Ohlmann, P, Khalife, K, Dibon, O, Hirsch, Jl, Furber, A, Nguyen-Khac, Jo, Delarche, N, Probst, V, Lim, P, Bayet, G, Dauphin, R, Levai, L, Galinier, M, Belhassane, A, Wiedemann, Jy, Fouche, R, Coisne, D, Henry, P, Schiele, F, Boueri, Z, Vaquette, B, Davy, Jm, Cottin, Y, D'Houdain, F, Danchin, N, Cassat, C, Messner, P, Elbaz, M, Coste, P, Zemour, G, Maupas, E, Feldman, L, Soto, Fx, Ferrari, E, Haltern, G, Heuer, H, Genth-Zotz, S, Loges, C, Stellbrink, C, Terres, W, Ferrar, M, Zeymer, U, Brachmann, J, Mudra, H, Vohringer, Hf, vom Dah, J, Kreuzer, J, Hill, S, Kleinertz, K, Kadel, C, Appel, Kf, Nienabe, C, Behrens, S, Frantz, S, Mehrhof, F, Krings, P, Hengstenberg, C, Lueders, S, Hanefel, C, Krulls-Munch, J, Dorse, T, Leschke, M, Nogai, K, Butter, C, Darius, H, Fichtlscherer, Hp, Schmitt, C, Kasisk, Hp, Dorr, M, Fran, N, Jereczek, M, Wiemer, M, Nickenig, G, Boudriot, E, Werner, G, Altila, T, Strasser, R, Baldus, S, Desaga, M, Buerke, M, Land, S, Schunkert, H, Schulze, Ho, Holmer, S, Sohn, Hy, Burkhardt, W, Lauer, B, Schwimmbeck, P, Schoeller, R, Lapp, H, Gross, M, Kindermann, I, Schuster, P, Yu, Cm, Lee, S, Merkely, B, Apro, D, Lupkovics, G, Edes, I, Ungi, I, Piroth, Z, Csapo, K, Dezsi, Ca, Herczeg, B, Sereg, M, Butnaru, A, Lewis, B, Rosenschein, U, Mosseri, M, Turgeman, Y, Pollak, A, Shotan, A, Hammerman, H, Rozenman, Y, Gottlieb, S, Atar, S, Weiss, A, Marmor, A, Iakobishvili, Z, Mascia, F, De Cesare, N, Piovaccari, G, Ceravolo, R, Fiscella, A, Salvioni, A, Silvestri, O, Moretti, L, Severi, S, Carmina, Mg, De Caterina, R, Fattore, L, Terrosu, P, Trimarco, B, Ardissino, D, Uguccioni, L, Auguadro, C, Gregorio, G, De Ferrari, G, Testa, R, Evola, R, De Servi, S, Sganzerla, P, Vassanelli, C, Brunelli, C, Scherillo, M, Tamburino, C, Limido, A, Luzza, F, Percoco, Gf, Sinagra, G, Volpe, M, Crea, F, Fedele, F, Rasetti, G, Cinelli, F, Merlini, P, Sisto, F, Biancoli, S, Fresco, C, Corrada, E, Casolo, G, Santini, M, D'Alessandro, B, Antoniucci, D, Tuccillo, B, Assennato, P, Puccioni, E, Pasquetto, G, Perna, Gp, Morgagni, G, Takizawa, K, Kato, K, Oshima, S, Yagi, M, Asai, T, Kamiya, H, Hirokami, M, Sakota, S, Sueyoshi, A, Shimomura, H, Hashimoto, T, Miyahara, M, Matsumura, T, Nakao, K, Kakuta, T, Nakamura, S, Nishi, Y, Kawajiri, K, Nagai, Y, Takahashi, A, Ikari, Y, Hara, K, Koga, T, Fujii, K, Tobaru, T, Tsunoda, R, Uchiyama, T, Hirayama, H, Fujimoto, K, Sakurai, S, Tanigawa, T, Ohno, M, Yamamoto, E, Ikuta, S, Kato, A, Kikuta, K, Takami, A, Chong, Wp, Ong, Tk, Yusof, A, Maskon, O, Kahar, A, Breedveld, Rw, Bendermacher, Pe, Hamer, Bj, Oude Ophuis AJ, Nierop, Pr, Westendorp, Ic, Beijerbacht, Hp, Herrman, Jp, van 't Hof AW, Troquay, Rp, van der Meer, P, Peters, Rh, van Rossum, P, Liem, A, Pieterse, Mg, van Eck JW, van der Zwaan, C, Pasupati, S, Elliott, J, Tisch, J, Hart, H, Luke, R, Scott, D, Ternouth, I, White, H, Hamer, A, Harding, S, Wilkins, G, O'Meeghan, T, Harrison, N, Nilsen, D, Thalamus, J, Aaberge, L, Brunvand, H, Lutterbey, G, Omland, Tm, Eritsland, J, Wiseth, R, Aase, O, Campos, C, Horna, M, Toce, L, Salazar, M, Przewlocki, T, Ponikowski, P, Kasprzak, J, Kopaczewski, J, Musial, W, Mazurek, W, Kawecka-Jaszcz, K, Pluta, W, Dobrzycki, S, Loboz-Grudzien, K, Lewczuk, J, Karwowski, D, Grajek, S, Dudek, D, Trusz-Gluza, M, Kornacewicz-Jach, Z, Gil, R, Ferreira, J, Gavina, C, Ferreira, R, Martins, D, Garcia-Rinaldi, R, Ufret, R, Vazquez-Tanus, J, Banchs, H, Wong, A, Tan, Hc, Guerra, M, Ebrahim, I, Roux, J, Blomerus, P, Saaiman, A, Corbett, C, Pillay, T, Freeman, V, Horak, A, Zambakides, C, Burgess, L, Yoon, Jh, Ahn, Th, Gwon, Hc, Seong, Iw, Kim, Hs, Jeong, Mh, Kim, Yd, Chae, Sc, Hernandez, Jm, Pique, M, Fernandez Portales, J, Paz, Ma, Lopez Palop, R, Iniguez, A, Diaz Fernandez, J, Alvarez, P, Sanz, E, Heras, M, Sala, J, Goicolea, J, Cruz Fernandez, J, Serra, A, Fernandez Ortiz, A, Calle, G, Barriales, V, Albarran, A, Curos, A, Molano Casimiro FJ, Suarez, Ma, Franco, Sn, Bayon, J, Suarez, J, Belchi, J, Moreu, J, San Martin, M, Melgares Moreno, R, Aguirre Salcedo, J, Gonzalez Juanatey JR, Martinez Romero, P, Galache Osuna JG, Albertsson, P, Diderholm, E, Lycksell, M, Rasmanis, G, Swahn, E, Cherfan, P, Christensen, K, Lundman, P, Larson, Le, Vasko, P, Pripp, Cm, Johansson, A, Moccetti, T, Corti, R, Pieper, M, Mach, F, Eberli, F, Jeger, R, Rickli, H, Vogt, P, Windecker, S, Wu, Cj, Kao, Hl, Charng, Mj, Chang, Kc, Chen, Zc, Tsa, Cd, Shyu, Kg, Lai, Wt, Hsieh, Ic, Hou, Jy, Yeh, Hi, Ueng, Kc, Yin, Wh, Timurkaynak, T, Yigit, Z, Yilmaz, M, Boyaci, A, Sahin, M, Goktekin, O, Bozkurt, E, Ercan, E, Yildirir, A, Muthusamy, R, Keeling, P, Levy, T, Zaman, A, Cohen, A, Gorog, D, Baumbach, A, Oldroyd, K, Kadr, H, Tait, G, Bellenger, N, Davis, G, Shakespeare, C, Senior, R, Bruce, D, Uren, N, Trouton, T, Ahsan, A, Hamed, A, Malik, I, Sarma, J, Millar-Craig, M, Robson, H, Kennon, S, Sprigings, D, Brodie, B, Kang, Gs, Thomas, G, Cheng, Sc, Espinoza, A, Kassas, S, Jafar, Z, Kumar, P, Izzo, M, Wiseman, A, Chandna, H, Felten, W, D'Urso, M, Gudipati, Cr, Coram, R, Gill, S, Bengtson, J, Chang, M, Raisinghani, A, Blankenship, J, Harbor, Wf, Kraft, P, Ashraf, R, Chambers, J, Albirini, A, Malik, A, Ziada, K, Slepian, M, Taussig, A, Vernon, H, Jetty, P, Islam, Ma, Canaday, D, Martin, T, Burchenal, Jj, Gencheff, N, Nygaard, T, Panchal, V, Merritt, R, Abrahams, L, Lambert, C, Reyes, P, Leimbach, W, Chhabra, A, Caputo, R, Imburgia, M, Erickson, B, Kleiman, N, Hunter, J, Dehning, M, Graham, B, Strain, J, White, Jk, Mcgarvey, J Jr, Henderson, D, Treasure, C 2nd, Mirro, M, Pancholy, S, Helmy, T, Westerhausen, D, Dib, N, Penny, W, Kim, H, Degregorio, M, Jay, D, Kmonicek, J, Berlowitz, M, Starling, M, Langevin, E, Nelson, R, Singer, A, Siachos, A, Gibson, G, Parrott, C, Held, J, Puleo, P, Wolford, T, Omar, B, Brilakis, E, Lewis, S, Heller, L, Brener, S, Addo, T, Lieberman, S, Eisenberg, D, Feldman, R, Waksman, R, Waltman, J, Schulman, S, Bounds, C, Voyce, S, Batchelor, W, Dobies, D, Pasnoori, V, Chandrashekhar, Y, Vetrovec, G, Azrin, M, Spriggs, D, Hirsch, C, Smucker, M, Chetcuti, S, Stella, R, Levite, H, Shoukfeh, M, Vidovich, M, Saucedo, J, Fintel, D, Low, R, Gellman, J, Ahsan, C, Unks, Dm, Tolleson, T, Ceccoli, H, Aggarwal, K, Bhaktaram, V, Olson, C, Decaro, M, Kaluski, E, Mehta, V, Puma, J, Singh, V, Fulmer, J, Lewis, D, Khadra, S, Staniloae, C, East, M, Sundram, Ps, Anderson, J, Wasserman, H, Guy, D, Brill, D, Kruse, K, Ebrahimi, R, Nguyen, T, Keating, F, Srivastava, R, Wassmer, P, Todd, J 3rd, Stein, M, Hamzeh, I, Laxson, D, Hodson, R, Puri, S, Vijayaraghavan, K, Gazmuri, R, Chu, A, Vijay, N, Rabinowitz, A, Block, T, Agarwal, H, Martin, J, Zetterlund, P, Fortuin, D, Macdonell, A 3rd, Zouzoulas, S, Chepuri, V, Schmalfuss, C, Karve, M, Aviles, R, Lieberman, E, Amlani, M, Murphy, S, Shapiro, T, Herzog, E, Ariani, K, Bhagwat, R, Hockstad, E, Kai, W, Saririan, M, Roth, R, Weiland, F, Atassi, K, Harjai, K, Muhlestein, J, Marsh, R, Shokooh, S, Nahhas, A, Labroo, A, Mayor, M, Koshy, S, Tariq, M, Rayos, G, Jones, S, Klugherz, B, Dewey, R, Rashid, Hu, Wohns, D, Feiring, A, Bowles, M, Rohrbeck, S, Monroe, Vs, De Gottlieb, A, Gumm, D, Brown, C 3rd, Chang, D, Kalaria, V, Minisi, A, Joumaa, M, Josephson, R, Kleczka, J, Silver, K, Coleman, P, Brachfeld, C, Saltiel, F, Reiner, J, Carell, E, Hanovich, G, Rosenberg, M, Das, G, Blick, D, and Universitat de Barcelona
- Subjects
Male ,Pyridines ,medicine.medical_treatment ,Kaplan-Meier Estimate ,law.invention ,Lactones ,Randomized controlled trial ,law ,Thrombin receptor antagonist ,clopidogrel ,placebo ,thienopyridine derivative ,vorapaxar ,antithrombocytic agent ,lactone ,proteinase activated receptor 1 ,pyridine derivative ,Coronary Artery Bypass ,Vorapaxar ,Cardiovascular diseases [NCEBP 14] ,Drugs ,General Medicine ,Middle Aged ,Combined Modality Therapy ,Cardiovascular diseases ,Cardiovascular Diseases ,Cardiology ,Platelet aggregation inhibitor ,Drug Therapy, Combination ,Female ,Plaquetes sanguínies ,Intracranial Hemorrhages ,Major bleeding ,Medicaments ,medicine.drug ,medicine.medical_specialty ,Acute coronary syndrome ,Bypass cardiopulmonary ,Hemorrhage ,Pharmacotherapy ,Blood platelets ,Double-Blind Method ,Angioplasty ,Internal medicine ,medicine ,Humans ,Receptor, PAR-1 ,Acute Coronary Syndrome ,Aged ,business.industry ,Malalties cardiovasculars ,medicine.disease ,Surgery ,Bypass cardiopulmonar ,business ,Platelet Aggregation Inhibitors ,Follow-Up Studies - Abstract
Item does not contain fulltext BACKGROUND: Vorapaxar is a new oral protease-activated-receptor 1 (PAR-1) antagonist that inhibits thrombin-induced platelet activation. METHODS: In this multinational, double-blind, randomized trial, we compared vorapaxar with placebo in 12,944 patients who had acute coronary syndromes without ST-segment elevation. The primary end point was a composite of death from cardiovascular causes, myocardial infarction, stroke, recurrent ischemia with rehospitalization, or urgent coronary revascularization. RESULTS: Follow-up in the trial was terminated early after a safety review. After a median follow-up of 502 days (interquartile range, 349 to 667), the primary end point occurred in 1031 of 6473 patients receiving vorapaxar versus 1102 of 6471 patients receiving placebo (Kaplan-Meier 2-year rate, 18.5% vs. 19.9%; hazard ratio, 0.92; 95% confidence interval [CI], 0.85 to 1.01; P=0.07). A composite of death from cardiovascular causes, myocardial infarction, or stroke occurred in 822 patients in the vorapaxar group versus 910 in the placebo group (14.7% and 16.4%, respectively; hazard ratio, 0.89; 95% CI, 0.81 to 0.98; P=0.02). Rates of moderate and severe bleeding were 7.2% in the vorapaxar group and 5.2% in the placebo group (hazard ratio, 1.35; 95% CI, 1.16 to 1.58; P
- Published
- 2012
10. Effect of Isradipine in Black Patients With Very Severe Hypertension
- Author
-
John Weinberg, Chris Zambakides, Victor Strugo, Pinhas Sareli, Daniel Skudicky, Jean Davis, and John Skoularigis
- Subjects
Isradipine ,Ambulatory blood pressure ,medicine.diagnostic_test ,business.industry ,Cardiac index ,Doppler echocardiography ,Blood pressure ,Drug control ,Anesthesia ,Heart rate ,Ambulatory ,Internal Medicine ,medicine ,business ,medicine.drug - Abstract
Fifty consecutive black patients with very severe hypertension (sitting diastolic blood pressure > or = 120 mm Hg and systolic > or = 210 mm Hg by the conventional cuff method) were treated in an open-label study (without a placebo or active drug control group) for 3 months with a long-acting preparation of isradipine (Dynacirc SRO), during which time serial changes in 24-h ambulatory blood pressure monitoring (ABPM), left ventricular (LV) mass index, and LV systolic function were evaluated. Mean 24-h ABPM was reduced from 184 +/- 13/119 +/- 6 to 148 +/- 18/96 +/- 11 mm Hg at 3 months (P < .0001). The reduction in BP was sustained for 24 h after dosing. Simultaneous BP measurements using a conventional cuff method and Dinamap were significantly different from the ABPM pre- and posttherapy, suggesting a marked "white coat" pressor effect. LV mass index regressed from 143 +/- 36 to 122 +/- 32 g/m2 at 3 months (P < .02). Heart rate and mean body weight were unchanged. Left ventricular performance was not adversely affected. Cardiac index and fractional shortening changed insignificantly, from 2.6 +/- 0.6 to 2.7 +/- 0.5 L/min/m2, and from 28 +/- 6 to 31 +/- 7%, respectively. Adverse effects were few and tended to disappear during the treatment period. All of the clinical laboratory parameters tested remained unchanged. We conclude that in this group of patients long-acting isradipine 1) showed a marked and sustained antihypertensive action demonstrated by 24-h ABPM; and 2) was well tolerated and associated with LV mass regression without adverse effect on systolic cardiac function.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1994
11. Variability of Tap Water Residual Chlorine and Microbial Counts at Spatially Resolved Points of Use
- Author
-
Pieri, Panayiota, primary, Andra, Syam S., additional, Charisiadis, Pantelis, additional, Demetriou, George, additional, Zambakides, Nicos, additional, and Makris, Konstantinos C., additional
- Published
- 2014
- Full Text
- View/download PDF
12. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study.
- Author
-
Sliwa K, Woodiwiss A, Kone VN, Candy G, Badenhorst D, Norton G, Zambakides C, Peters F, Essop R, Sliwa, Karen, Woodiwiss, Angela, Kone, Veuvette N, Candy, Geoffrey, Badenhorst, Danelle, Norton, Gavin, Zambakides, Chris, Peters, Ferande, and Essop, Rafique
- Published
- 2004
- Full Text
- View/download PDF
13. Comparison of captopril-thiazide and enalapril-thiazide combinations in the management of mild to moderate black hypertensive patients: how important is diuretic dose and duration of action of the ACE-inhibitor?
- Author
-
J, Skoularigis, V, Strugo, C, Zambakides, S, Eintracht, K, Reddy, E, Tshele, D, Smith, and P, Sareli
- Subjects
Male ,Captopril ,Time Factors ,Sodium Chloride Symporter Inhibitors ,Body Weight ,Black People ,Angiotensin-Converting Enzyme Inhibitors ,Blood Pressure ,Middle Aged ,Benzothiadiazines ,Echocardiography, Doppler ,Ventricular Function, Left ,Drug Combinations ,Double-Blind Method ,Enalapril ,Echocardiography ,Heart Rate ,Hypertension ,Humans ,Female ,Diuretics ,Antihypertensive Agents - Abstract
A double-blind, randomized, parallel-group study was performed to compare the efficacy and tolerability of captopril-thiazide and enalapril-thiazide combinations. After a 3-week placebo run-in period, 47 Black patients with mild to moderate essential hypertension (mean 24-hour diastolic blood pressure (BP)90 mmHg and115 mmHg) were randomized to receive 1 of 2 combination tablets: captopril 50 mg plus hydrochlorothiazide 25 mg (CAP, n = 24) or enalapril 20 mg plus hydrochlorothiazide 12.5 mg (COR, n = 23) once daily. After 12 weeks of active treatment the mean 24-hour ambulatory BP was reduced from 152 +/- 11/99 +/- 6 to 133 +/- 13/86 +/- 7 mmHg (p0.005) in the CAP group and 157 +/- 15/100 +/- 6 to 141 +/- 18/90 +/- 12 in the COR group (p0.005). Target BP (24-hour diastolic BP90 mmHg) was achieved in 75% (18/24) of patients on CAP and 48% (11/23) on COR (p = n.s.). 24-hour BP load fell significantly with both CAP (from 69% to 34%, p0.001) and COR (from 67% to 37%, p0.001). Left ventricular mass index decreased by 7% with CAP and 11% with COR. Cardiac index and fractional shortening remained essentially unchanged in both groups. Both treatments were well tolerated and overall incidence of side effects was very low. It is concluded that both CAP and COR are effective, safe first-line antihypertensive choices in Black patients with mild to moderate hypertension with the former showing a trend towards greater efficacy than the latter.
- Published
- 1996
14. A33 The use of myocardial perfusion imaging in the clinical evaluation and risk stratification of coronary artery disease
- Author
-
Elena Libhaber, Carlos D. Libhaber, Mohammed R. Essop, M.D.T.H.W. Vangu, C.A. Zambakides, M. Adams, T. Kotze, J.D. Esser, and S. Perumal
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,General Medicine ,medicine.disease ,Coronary artery disease ,Myocardial perfusion imaging ,Internal medicine ,Risk stratification ,medicine ,Cardiology ,Radiology, Nuclear Medicine and imaging ,Radiology ,business ,Clinical evaluation - Published
- 2004
15. Effect of isradipine in black patients with very severe hypertension. 24-hour ambulatory blood pressure monitoring and echocardiographic evaluation
- Author
-
J, Skoularigis, J, Weinberg, V, Strugo, J, Davis, D, Skudicky, C, Zambakides, and P, Sareli
- Subjects
Adult ,Male ,Black People ,Blood Pressure ,Blood Pressure Monitoring, Ambulatory ,Middle Aged ,Echocardiography, Doppler ,Ventricular Function, Left ,Electrocardiography ,Heart Rate ,Delayed-Action Preparations ,Hypertension ,Humans ,Female ,Isradipine ,Aged - Abstract
Fifty consecutive black patients with very severe hypertension (sitting diastolic blood pressureor = 120 mm Hg and systolicor = 210 mm Hg by the conventional cuff method) were treated in an open-label study (without a placebo or active drug control group) for 3 months with a long-acting preparation of isradipine (Dynacirc SRO), during which time serial changes in 24-h ambulatory blood pressure monitoring (ABPM), left ventricular (LV) mass index, and LV systolic function were evaluated. Mean 24-h ABPM was reduced from 184 +/- 13/119 +/- 6 to 148 +/- 18/96 +/- 11 mm Hg at 3 months (P.0001). The reduction in BP was sustained for 24 h after dosing. Simultaneous BP measurements using a conventional cuff method and Dinamap were significantly different from the ABPM pre- and posttherapy, suggesting a marked "white coat" pressor effect. LV mass index regressed from 143 +/- 36 to 122 +/- 32 g/m2 at 3 months (P.02). Heart rate and mean body weight were unchanged. Left ventricular performance was not adversely affected. Cardiac index and fractional shortening changed insignificantly, from 2.6 +/- 0.6 to 2.7 +/- 0.5 L/min/m2, and from 28 +/- 6 to 31 +/- 7%, respectively. Adverse effects were few and tended to disappear during the treatment period. All of the clinical laboratory parameters tested remained unchanged. We conclude that in this group of patients long-acting isradipine 1) showed a marked and sustained antihypertensive action demonstrated by 24-h ABPM; and 2) was well tolerated and associated with LV mass regression without adverse effect on systolic cardiac function.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1994
16. Scleroderma after silicone augmentation mammoplasty. A report of 2 cases
- Author
-
P E, Marik, A L, Kark, and A, Zambakides
- Subjects
Adult ,Scleroderma, Localized ,Silicones ,Humans ,Female ,Breast ,Prostheses and Implants ,Middle Aged ,Surgery, Plastic - Abstract
Two patients who developed scleroderma after silicone breast augmentation are described. One patient presented with the classic features of systemic sclerosis, and the other with calcinosis, Raynaud's phenomenon oesophageal dysfunction, sclerodactyly, and telangiectasia (CREST syndrome). The connective tissue diseases associated with mammoplasty are reviewed.
- Published
- 1990
17. A35 imaging in the evaluation of coronary artery disease in patients with LBBB
- Author
-
Libhaber, C.D., primary, Libhaber, E., additional, Kotze, T., additional, Perumal, S., additional, Adams, M., additional, Zambakides, C.A., additional, Esser, J.D., additional, Essop, M.R., additional, and Vangu, M.D.T.H.W., additional
- Published
- 2004
- Full Text
- View/download PDF
18. A34 Comparison between left ventricular ejection fraction measured by M-mode echocardiography and by ECG-gated myocardial perfusion imaging using QGS
- Author
-
Libhaber, C.D., primary, Libhaber, E., additional, Kotze, T., additional, Perumal, S., additional, Adams, M., additional, Zambakides, C.A., additional, Esser, J.D., additional, Essop, M.R., additional, and Vangu, M.D.T.H.W., additional
- Published
- 2004
- Full Text
- View/download PDF
19. A33 The use of myocardial perfusion imaging in the clinical evaluation and risk stratification of coronary artery disease
- Author
-
Libhaber, C.D., primary, Libhaber, E., additional, Kotze, T., additional, Perumal, S., additional, Adams, M., additional, Zambakides, C.A., additional, Esser, J.D., additional, Essop, M.R., additional, and Vangu, M.D.T.H.W., additional
- Published
- 2004
- Full Text
- View/download PDF
20. 23. Myocardial perfusion imaging - the Johannesburg experience
- Author
-
Libhaber, C. D., primary, Vangu, M. D.T.H.W., additional, Kotze, T., additional, Libhaber, E., additional, Candy, G. P., additional, Zambakides, C. A., additional, Kachope, J., additional, Esser, J. D., additional, Jennings, P. A., additional, Perumal, S., additional, Wadee, A., additional, Essop, M. R., additional, and Sareli, P., additional
- Published
- 2002
- Full Text
- View/download PDF
21. A34 Comparison between left ventricular ejection fraction measured by M-mode echocardiography and by ECG-gated myocardial perfusion imaging using QGS
- Author
-
Mohammed R. Essop, C.A. Zambakides, Carlos D. Libhaber, S. Perumal, M.D.T.H.W. Vangu, T. Kotze, M. Adams, J.D. Esser, and Elena Libhaber
- Subjects
Myocardial perfusion imaging ,medicine.medical_specialty ,Ejection fraction ,medicine.diagnostic_test ,M Mode Echocardiography ,business.industry ,Internal medicine ,Cardiology ,Medicine ,Radiology, Nuclear Medicine and imaging ,Perfusion scanning ,General Medicine ,business - Published
- 2004
22. A35 imaging in the evaluation of coronary artery disease in patients with LBBB
- Author
-
M. Adams, T. Kotze, C.A. Zambakides, Elena Libhaber, S. Perumal, J.D. Esser, Mohammed R. Essop, Carlos D. Libhaber, and M.D.T.H.W. Vangu
- Subjects
Coronary artery disease ,medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Cardiology ,Radiology, Nuclear Medicine and imaging ,In patient ,General Medicine ,medicine.disease ,business - Published
- 2004
23. 23. Myocardial perfusion imaging - the Johannesburg experience
- Author
-
C.A. Zambakides, Geoffrey P. Candy, J. Kachope, Pinhas Sareli, P. A. Jennings, S. Perumal, Elena Libhaber, Carlos D. Libhaber, M.D.T.H.W. Vangu, Mohammed R. Essop, J.D. Esser, T. Kotze, and A. S. Wadee
- Subjects
medicine.medical_specialty ,Myocardial perfusion imaging ,medicine.diagnostic_test ,business.industry ,medicine ,Radiology, Nuclear Medicine and imaging ,Perfusion scanning ,General Medicine ,Radiology ,business - Published
- 2002
24. Effect of Isradipine in Black Patients With Very Severe Hypertension
- Author
-
Skoularigis, John, primary, Weinberg, John, additional, Strugo, Victor, additional, Davis, Jean, additional, Skudicky, Daniel, additional, Zambakides, Chris, additional, and Sareli, Pinhas, additional
- Published
- 1994
- Full Text
- View/download PDF
25. Efficacy of two ace-inhibitor/thiazide combinations as monotherapy for mild to moderate hypertension: double-blind randomized trial using ambulatory blood pressure monitoring
- Author
-
Strugo, E Tshele, John Skoularigis, S Eintracht, Pinhas Sareli, and C Zambakides
- Subjects
medicine.medical_specialty ,Ambulatory blood pressure ,business.industry ,law.invention ,Double blind ,Randomized controlled trial ,law ,Internal medicine ,ACE inhibitor ,Internal Medicine ,medicine ,Physical therapy ,business ,Thiazide ,medicine.drug - Published
- 1995
26. A33The use of myocardial perfusion imaging in the clinical evaluation and risk stratification of coronary artery disease
- Author
-
Libhaber, C.D., Libhaber, E., Kotze, T., Perumal, S., Adams, M., Zambakides, C.A., Esser, J.D., Essop, M.R., and Vangu, M.D.T.H.W.
- Published
- 2004
27. A34Comparison between left ventricular ejection fraction measured by M-mode echocardiography and by ECG-gated myocardial perfusion imaging using QGS
- Author
-
Libhaber, C.D., Libhaber, E., Kotze, T., Perumal, S., Adams, M., Zambakides, C.A., Esser, J.D., Essop, M.R., and Vangu, M.D.T.H.W.
- Published
- 2004
28. A35imaging in the evaluation of coronary artery disease in patients with LBBB
- Author
-
Libhaber, C.D., Libhaber, E., Kotze, T., Perumal, S., Adams, M., Zambakides, C.A., Esser, J.D., Essop, M.R., and Vangu, M.D.T.H.W.
- Published
- 2004
29. Efficacy of two ace-inhibitor/thiazide combinations as monotherapy for mild to moderate hypertension: Double-blind randomized trial using ambulatory blood pressure monitoring
- Author
-
Skoularigis, J, Strugo, V, Enitracht, S, Zambakides, C, Tshele, E, and Sareli, P
- Published
- 1995
- Full Text
- View/download PDF
30. Scleroderma after silicone augmentation mammoplasty. A report of 2 cases.
- Author
-
Marik PE, Kark AL, and Zambakides A
- Subjects
- Adult, Female, Humans, Middle Aged, Breast surgery, Prostheses and Implants adverse effects, Scleroderma, Localized chemically induced, Silicones adverse effects, Surgery, Plastic adverse effects
- Abstract
Two patients who developed scleroderma after silicone breast augmentation are described. One patient presented with the classic features of systemic sclerosis, and the other with calcinosis, Raynaud's phenomenon oesophageal dysfunction, sclerodactyly, and telangiectasia (CREST syndrome). The connective tissue diseases associated with mammoplasty are reviewed.
- Published
- 1990
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.